2023 - Research.com Molecular Biology in Japan Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Genetics and Molecular Biology in Japan Leader Award
2012 - Fellow of the American Association for the Advancement of Science (AAAS)
Cell biology connects with themes related to Embryo in his study. His Embryo study frequently links to related topics such as Genetics. His Genetics study frequently links to other fields, such as Messenger RNA. Kohei Miyazono undertakes interdisciplinary study in the fields of Messenger RNA and In situ hybridization through his research. In his papers, he integrates diverse fields, such as In situ hybridization and Molecular biology. He carries out multidisciplinary research, doing studies in Molecular biology and Cell biology. His study ties his expertise on Activator (genetics) together with the subject of Biochemistry. As part of his studies on Activator (genetics), he frequently links adjacent subjects like Receptor. His Receptor study frequently draws parallels with other fields, such as Interleukin-21 receptor.
BMPR2, Bone morphogenetic protein receptor and Bone morphogenetic protein 7 are all intrinsically tied to his study in Bone morphogenetic protein. He performs multidisciplinary study in BMPR2 and Bone morphogenetic protein in his work. A significant part of his In vitro research incorporates Bone morphogenetic protein 2 and Osteoblast studies. His Bone morphogenetic protein 2 study frequently links to other fields, such as Biochemistry. His research links Bone morphogenetic protein 7 with Biochemistry. His Osteoblast study frequently links to adjacent areas such as In vitro. Kohei Miyazono conducted interdisciplinary study in his works that combined Gene and Messenger RNA. Kohei Miyazono merges Messenger RNA with Gene in his study. He undertakes interdisciplinary study in the fields of Cell biology and Molecular biology through his works.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
TGF-beta signalling from cell membrane to nucleus through SMAD proteins
Carl-Henrik Heldin;Kohei Miyazono;Peter ten Dijke.
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.
Masao Saitoh;Hideki Nishitoh;Makiko Fujii;Kohsuke Takeda.
The EMBO Journal (1998)
Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways
Hidenori Ichijo;Eisuke Nishida;Kenji Irie;Peter ten Dijke.
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
H. Cabral;Y. Matsumoto;K. Mizuno;Q. Chen.
Nature Nanotechnology (2011)
Modulation of microRNA processing by p53
Hiroshi I. Suzuki;Kaoru Yamagata;Koichi Sugimoto;Takashi Iwamoto.
TGFβ signalling: a complex web in cancer progression
Hiroaki Ikushima;Kohei Miyazono.
Nature Reviews Cancer (2010)
ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
Kei Tobiume;Atsushi Matsuzawa;Takumi Takahashi;Hideki Nishitoh.
EMBO Reports (2001)
Smad6 inhibits signalling by the TGF-Beta superfamily
Takeshi Imamura;Masao Takase;Ayako Nishihara;Eiichi Oeda.
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Atsuhito Nakao;Takeshi Imamura;Takeshi Imamura;Serhiy Souchelnytskyi;Masahiro Kawabata.
The EMBO Journal (1997)
Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin
Toshio Kitamura;Tsuyoshi Tange;Takashi Terasawa;Shigeru Chiba.
Journal of Cellular Physiology (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: